Citations

Showing 10 of 108094 citations.

The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis
Qiu, Jiajing , Salama, Mohamed E. , Hu, Cing Siang, Wang, Xiaoli , Li, Yan , Hoffman, Ronald

Mayo Clinic

Blood Advances | May 18, 2018 | Volume: 2 | Issue: 10 | Pages: 1130-1145

10.1182/bloodadvances.2017015073 | PMID 29776986 Get It

Key PointsSVECs support the development of hematopoiesis in MF. LCs and SVECs each have distinct properties and functions that differ between normal and MF spleens.
ADHERENCE TO THE PECARN PEDIATRIC HEAD INJURY RULE IN TWO CANADIAN EMERGENCY SETTINGS
Gariépy, Martin , Lelaidier-Hould, Lania, Truchon, Catherine, Sauvé, Louise , Plante, Patrick , Lesage, Nathalie, Gravel, Jocelyn , Turcotte, Stéphane , Légaré, France , Melnick, Edward R. , Hess, Erik P. , Witteman, Holly , Archambault, Patrick

Mayo Clinic

Paediatrics & Child Health | May 18, 2018 | Volume: 23 | Issue: suppl_1 | Pages: e9-e10

10.1093/pch/pxy054.024 Get It

Abstract BACKGROUND Head computerized tomography (CT) increases the risk of cancer in children and should be carefully prescribed to paediatric patients with head injury. The Pediatric Emergency Care Applied Network (PECARN) validated a rule to identify children at risk of a clinically important traumatic brain injury (TBI) needing a head CT. OBJECTIVES The objective was to evaluate adherence to the PECARN rule as a function of CT overuse (defined as a prescribed CT when not recommended by the rule) and underuse rates (no CT performed when recommended) in two Canadian emergency departments (EDs). DESIGN/METHODS We conducted a retrospective chart review of children under 17 years of age seen in 2016 in a paediatric Level I (site 1) and a general Level II (site 2) trauma center. We reviewed charts to determine the appropriateness of head CT use according to the PECARN rule in a random subset of children presenting with a head trauma. Mandatory inclusion criteria were (1) that the head trauma occurred in the 24 hours prior to arrival to the ED, (2) a GCS over 13 and (3) and at least one sign or symptom of minor TBI. Patients with a special condition that could have influenced the decision to order a head CT were automatically excluded. When a patient did not receive a head CT when recommended by the rule, we reviewed medical records to determine if the patient has returned to the ED after his discharge within the next 30 days. RESULTS 1546 eligible patients younger than 17 years consulted during the study period. Of the 203 randomly selected cases per setting, 16 (7.9%) and 24 (12%) respectively from sites 1 and 2 had a head CT performed. For the younger group (< 2), both overuse and underuse rates were below 3%. For the older group, overuse rates were higher in site 2 (9.3% (95%CI:4.8–17%) vs. 1.2% (95%CI:0.2–6.5%) (P=.03)) and there was no difference in underuse rates (22% (95%CI:6.3–55%) vs 39% (95%CI:18–65%) (P=.65)). For children who did not receive a head CT when recommended, none returned to the ED for a related complication. CONCLUSION Overall, even if there may be slightly more overuse of head CTs in the Level II trauma center, results showed an excellent agreement with the PECARN rule when CT was not recommended. However, results also showed a deviation when CT was recommended, where a higher portion of patients than expected did not receive a head CT. Reasons to explain this behaviour will need further exploration.
DNA methylation and FoxO3a regulate PHLPP1 expression in chondrocytes
Becerra, Clara M. Castillejo , Mattson, Anna M., Molstad, David H. H., Lorang, Ian M., Bradley, Elizabeth W. , Bradley, Elizabeth W , Castillejo Becerra, Clara M , Westendorf, Jennifer J.

Mayo Clinic

Journal of Cellular Biochemistry | May 18, 2018 | Volume: 119 | Issue: 9 | Pages: 7470-7478

10.1002/jcb.27056 | PMID 29775231 Get It

AbstractThe protein phosphatase Phlpp1 is an essential enzyme for proper chondrocyte function. Altered Phlpp1 levels are associated with cancer and degenerative diseases such as osteoarthritis. While much is known about the post‐transcriptional mechanisms controlling Phlpp1 levels, transcriptional regulation of the Phlpp1 gene locus is underexplored. We previously showed that CpG methylation of the PHLPP1 promoter is lower in osteoarthritic cartilage than in normal cartilage, and indirectly correlates with gene expression. Here we further defined the effects of DNA methylation on PHLPP1 promoter activity in chondrocytes. We cloned a 1791 bp fragment of the PHLPP1 promoter (−1589:+202) and found that the first 500 bp were required for maximal promoter activity. General methylation of CpG sites within this fragment significantly blunts transcriptional activity, whereas site‐specific methyltransferases HhaI or HpaII decrease transcriptional activation by approximately 50%. We located putative FoxO consensus sites within the PHLPP1 promoter region. Inhibition of DNA methylation by incorporation of 5‐azacytidine increases Phlpp1 mRNA levels, but FoxO inhibition abolishes this induction. To determine which FoxO transcription factor mediates Phlpp1 expression, we performed overexpression and siRNA‐mediated knock down experiments. Overexpression of FoxO3a, but not FoxO1, increases Phlpp1 levels. Likewise, siRNAs targeting FoxO3a, but not FoxO1, diminished Phlpp1 levels. Last, FoxO inhibition increases glycosaminoglycan staining of cultured chondrocytes and leads to concomitant increases in FGF18 and HAS2 expression. Together, these data demonstrate that CpG methylation and FoxO3a regulate PHLPP1 expression.
Mindfulness Meditation and Interprofessional Cardiopulmonary Resuscitation: A Mixed-Methods Pilot Study
Kelm, Diana J. , Ridgeway, Jennifer L. , Gas, Becca L. , Mohan, Monali , Cook, David A. , Nelson, Darlene R. , Benzo, Roberto P. , Ridgeway, Jennifer L

Mayo Clinic

Teaching and Learning in Medicine | May 18, 2018 | Volume: 30 | Issue: 4 | Pages: 433-443

10.1080/10401334.2018.1462186 | PMID 29775080 Get It

Feasibility, safety, and changes in systolic blood pressure associated with endovascular revascularization of symptomatic and chronically occluded cervical internal carotid artery using a newly suggested radiographic classification of chronically occluded
Starke, Robert M. , Atallah, Elias , Chalouhi, Nohra , Singla, Amit , Guerrero, Waldo R. , Nakagawa, Daichi , Samaniego, Edgar A. , Mbabuike, Nnenna, Siddiqui, Adnan H. , Novakovic, Roberta, White, Jonathan, Schirmer, Clemens M. , Brott, Thomas G. , Shallwani, Hussain , Hopkins, L. Nelson , Siddiqui, Adnan H , Samaniego, Edgar A , Schirmer, Clemens M , Hasan, David , Zanaty, Mario , Jabbour, Pascal , Tawk, Rabih G. , Levy, Elad I. , White, Jonathan A.

Mayo Clinic

Journal of Neurosurgery | May 18, 2018 | Volume: No volume available | Issue: No issue available | Pages: 1-10

10.3171/2018.1.jns172858 | PMID 29775153 Get It

OBJECTIVE The overall risk of ischemic stroke from a chronically occluded internal carotid artery (COICA) is around 5%–7% per year despite receiving the best available medical therapy. Here, authors propose a radiographic classification of COICA that can be used as a guide to determine the technical success and safety of endovascular recanalization for symptomatic COICA and to assess the changes in systemic blood pressure following successful revascularization. METHODS The radiographic images of 100 consecutive subjects with COICA were analyzed. A new classification of COICA was proposed based on the morphology, location of occlusion, and presence or absence of reconstitution of the distal ICA. The classification was used to predict successful revascularization in 32 symptomatic COICAs in 31 patients, five of whom were female (5/31 [16.13%]). Patients were included in the study if they had a COICA with ischemic symptoms refractory to medical therapy. Carotid artery occlusion was defined as 100% cross-sectional occlusion of the vessel lumen as documented on CTA or MRA and confirmed by digital subtraction angiography. RESULTS Four types (A–D) of radiographic COICA were identified. Types A and B were more amenable to safe revascularization than types C and D. Recanalization was successful at a rate of 68.75% (22/32 COICAs; type A: 8/8; type B: 8/8; type C: 4/8; type D: 2/8). The perioperative complication rate was 18.75% (6/32; type A: 0/8 [0%]; type B: 1/8 [12.50%]; type C: 3/8 [37.50%], type D: 2/8 [25.00%]). None of these complications led to permanent morbidity or death. Twenty (64.52%) of 31 subjects had improvement in their symptoms at the 2–6 months’ follow-up. A statistically significant decrease in systolic blood pressure (SBP) was noted in 17/21 (80.95%) patients who had successful revascularization, which persisted on follow-up (p = 0.0001). The remaining 10 subjects in whom revascularization failed had no significant changes in SBP (p = 0.73). CONCLUSIONS The pilot study suggested that our proposed classification of COICA may be useful as an adjunctive guide to determine the technical feasibility and safety of revascularization for symptomatic COICA using endovascular techniques. Additionally, successful revascularization may lead to a significant decrease in SBP postprocedure. A Phase 2b trial in larger cohorts to assess the efficacy of endovascular revascularization using our COICA classification is warranted.
Canine Distemper Virus Spread and Transmission to Naive Ferrets: Selective Pressure on Signaling Lymphocyte Activation Molecule-Dependent Entry
Sawatsky, Bevan , Cattaneo, Roberto , Messling, Veronika von , von Messling, Veronika

Mayo Clinic

Journal of Virology | May 18, 2018 | Volume: 92 | Issue: 15 | Pages: No page available

10.1128/jvi.00669-18 | PMID 29793948 Get It

Morbilliviruses such as measles virus, rinderpest virus, and canine distemper virus (CDV) are highly contagious. Despite extensive knowledge of how morbilliviruses interact with their receptors, little is known about how those interactions influence viral transmission to naive hosts. In a ferret model of CDV contact transmission, we showed that sequential use of the signaling lymphocytic activation molecule (SLAM) and nectin-4 receptors is essential for transmission. In one animal infected with a SLAM-blind CDV, we documented mild viremia due to the acquisition of three compensatory mutations within or near the SLAM-binding surface. The interaction, however, was not sufficient to cause disease or sustain transmission to naive contacts. This work confirms the sequential roles of SLAM and nectin-4 in morbillivirus transmission and highlights the selective pressure directed toward productive interactions with SLAM.
SP037PD-L1 STAINING DOES NOT DISTINGUISH INTERSTITIAL NEPHRITIS SECONDARY TO IMMUNE CHECKPOINT INHIBITORS
Herrmann, Sandra M. , Cornell, Lynn D.

Mayo Clinic

Nephrology Dialysis Transplantation | May 18, 2018 | Volume: 33 | Issue: suppl_1 | Pages: i358-i358

10.1093/ndt/gfy104.sp037 Get It

Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real‐World Data From a Large U.S. Claims Database
Houten, Holly K. Van , Sangaralingham, Lindsey R. , Talwalkar, Jayant A., Van Houten, Holly K, Allen, Alina M. , McCoy, Rozalina G.

Mayo Clinic

Hepatology | May 18, 2018 | Volume: 68 | Issue: 6 | Pages: 2230-2238

10.1002/hep.30094 | PMID 29774589 Get It

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing. The health care burden resulting from the multidisciplinary management of this complex disease is unknown. We assessed the total health care cost and resource utilization associated with a new NAFLD diagnosis, compared with controls with similar comorbidities. We used OptumLabs Data Warehouse, a large national administrative claims database with longitudinal health data of over 100 million individuals enrolled in private and Medicare Advantage health plans. We identified 152,064 adults with a first claim for NAFLD between 2010 and 2014, of which 108,420 were matched 1:1 by age, sex, metabolic comorbidities, length of follow‐up, year of diagnosis, race, geographic region, and insurance type to non‐NAFLD contemporary controls from the OptumLabs Data Warehouse database. Median follow‐up time was 2.6 (range 1‐6.5) years. The final study cohort consisted of 216,840 people with median age 55 (range 18‐86) years, 53% female, 78% white. The total annual cost of care per NAFLD patient with private insurance was $7,804 (interquartile range [IQR] $3,068‐$18,688) for a new diagnosis and $3,789 (IQR $1,176‐$10,539) for long‐term management. These costs are significantly higher than the total annual costs of $2,298 (IQR $681‐$6,580) per matched control with similar metabolic comorbidities but without NAFLD. The largest increases in health care utilization that may account for the increased costs in NAFLD compared with controls are represented by liver biopsies (relative risk [RR] = 55.00, 95% confidence interval [CI] 24.48‐123.59), imaging (RR = 3.95, 95% CI 3.77‐4.15), and hospitalizations (RR = 1.87, 95% CI 1.73‐2.02). Conclusion: The costs associated with the care for NAFLD independent of its metabolic comorbidities are very high, especially at first diagnosis. Research efforts shouldfocus on identification of underlying determinants of use, sources of excess cost, and development of cost‐effective diagnostic tests.
A man with easy bruising, heart failure, and organomegaly
Tolkachjov, Stanislav N. , Lehman, Julia S. , Lehman, Julia S

Mayo Clinic

International Journal of Dermatology | May 18, 2018 | Volume: 57 | Issue: 12 | Pages: 1439-1441

10.1111/ijd.14053 | PMID 29774527 Get It